RETATRUTIDE

Retatrutide is an investigational synthetic peptide studied in scientific research for its activity at the GLP-1, GIP and glucagon receptor systems.

It is commonly characterised in research literature as a triple receptor agonist and is of scientific interest for investigating receptor pharmacology, signalling mechanisms and metabolic biological pathways.

Research Areas

• GLP-1 receptor signalling

• GIP receptor signalling

• Glucagon receptor signalling

• Triple-receptor pharmacology

• Cellular and metabolic signalling pathways

• Comparative receptor research

Product Information

Compound: Retatrutide
Category: Research Compound
Form: Lyophilised Powder
Intended Application: Laboratory and scientific research
Status: Investigational research compound

⚠ STRICTLY FOR RESEARCH USE ONLY

This product is supplied exclusively for legitimate laboratory, analytical and scientific research purposes.

NOT FOR HUMAN CONSUMPTION OR HUMAN USE.
NOT FOR VETERINARY USE.
NOT A THERAPEUTIC PRODUCT OR MEDICINE.
NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE OR MEDICAL CONDITION.

No information provided on this website should be interpreted as medical advice, dosage guidance, therapeutic instruction or a recommendation for personal use.

Purchasers are responsible for ensuring that their acquisition, possession, handling and use of this product complies with applicable Australian laws and regulations.

Sydney Peptides — Research • Quality • Innovation